Lupin Limited has informed the Exchange regarding a press release dated November 23, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Canagliflozin Tablets".
Lupin Limited has informed the Exchange regarding a press release dated November 23, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Canagliflozin Tablets".